UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer

Clinical cancer research, 2015-06, Vol.21 (12), p.2763-2770

2015

Volltextzugriff (PDF)

Key Role of Phosphoinositide 3-Kinase Class IB in Pancreatic Cancer

Clinical cancer research, 2010-10, Vol.16 (20), p.4928-4937

2010

Volltextzugriff (PDF)

Therapy-induced normal tissue damage promotes breast cancer metastasis

iScience, 2024-01, Vol.27 (1), p.108503-108503, Article 108503

2024

Volltextzugriff (PDF)

Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer

Breast cancer research : BCR, 2018-09, Vol.20 (1), p.103-13, Article 103

2018

Volltextzugriff (PDF)

Targeting phosphoinositide 3-kinase pathways in pancreatic cancer--from molecular signalling to clinical trials

Anti-cancer agents in medicinal chemistry, 2011-06, Vol.11 (5), p.455-463

2011

Volltextzugriff (PDF)

Regulation of ErbB2 receptor status by the proteasomal DUB POH1

PloS one, 2009-05, Vol.4 (5), p.e5544-e5544

2009

Volltextzugriff (PDF)

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer

Journal for immunotherapy of cancer, 2020-08, Vol.8 (2), p.e000698

2020

Volltextzugriff (PDF)

Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study

Breast cancer research : BCR, 2017-10, Vol.19 (1), p.113-15, Article 113

2017

Volltextzugriff (PDF)

Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna

NPJ breast cancer, 2021-02, Vol.7 (1), p.15-8, Article 15

2021

Volltextzugriff (PDF)

Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

JNCI : Journal of the National Cancer Institute, 2016-11, Vol.108 (11), p.djw149

2016

Volltextzugriff (PDF)

Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

Journal of clinical oncology, 2021-01, Vol.39 (2), p.126-135

2021

Volltextzugriff (PDF)

Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients

Breast cancer research and treatment, 2024-07, Vol.206 (1), p.195-205

2024

Volltextzugriff (PDF)

Abstract P5-06-04: Prognostic value of EndoPredict and Oncotype Recurrence Score according to patient's age

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-06-04

2020

Volltextzugriff (PDF)

Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

JAMA oncology, 2018-04, Vol.4 (4), p.545

2018

Volltextzugriff (PDF)

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

Breast cancer research and treatment, 2019-07, Vol.176 (2), p.377-386

2019

Volltextzugriff (PDF)

Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer

Clinical cancer research, 2020-09, Vol.26 (17), p.4682-4687

2020

Volltextzugriff (PDF)

Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease

Clinical cancer research, 2016-05, Vol.22 (10), p.2405-2416

2016

Volltextzugriff (PDF)

Abstract PS18-10: Intratumoural heterogeneity in PgR expression: Molecular and prognostic significance

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS18-10-PS18-10

2021

Volltextzugriff (PDF)

Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy

European journal of cancer (1990), 2022-03, Vol.164, p.52-61

2022

Volltextzugriff (PDF)

Abstract P3-07-05: Correlation between and molecular drivers of oncotype DX, prosigna, EndoPredict and breast cancer index: A TransATAC study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-07-05

2020

Volltextzugriff (PDF)

Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers

Clinical cancer research, 2022-10, Vol.28 (20), p.4494-4508

2022

Volltextzugriff (PDF)

Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms

Current pharmaceutical design, 2013-02, Vol.19 (4), p.680-686

2013

Volltextzugriff (PDF)

Abstract 5294: Biomarkers in residual disease after neoadjuvant chemotherapy of breast cancer predict long-term outcome

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5294-5294

2015

Volltextzugriff (PDF)

Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study

Clinical cancer research, 2020-02, Vol.26 (3), p.623-631

2020

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(62)
Dissertationen
(1)

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer

Key Role of Phosphoinositide 3-Kinase Class IB in Pancreatic Cancer

Therapy-induced normal tissue damage promotes breast cancer metastasis

Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer

Targeting phosphoinositide 3-kinase pathways in pancreatic cancer--from molecular signalling to clinical trials

Regulation of ErbB2 receptor status by the proteasomal DUB POH1

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer

Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study

Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna

Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients

Abstract P5-06-04: Prognostic value of EndoPredict and Oncotype Recurrence Score according to patient's age

Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer

PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer

Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease

Abstract PS18-10: Intratumoural heterogeneity in PgR expression: Molecular and prognostic significance

Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy

Abstract P3-07-05: Correlation between and molecular drivers of oncotype DX, prosigna, EndoPredict and breast cancer index: A TransATAC study

Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers

Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms

Abstract 5294: Biomarkers in residual disease after neoadjuvant chemotherapy of breast cancer predict long-term outcome

Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study

Suchergebnisse filtern